Issued Patents All Time
Showing 26–50 of 80 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9238799 | Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses | Alexander G. Pletnev, Amber R. Engel | 2016-01-19 |
| 9090873 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Ching-Juh Lai | 2015-07-28 |
| 9034343 | Attenuated human parainfluenza virus, methods and uses thereof | Mario H. Skiadopoulos, Peter L. Collins, Sheila Nolan | 2015-05-19 |
| RE45123 | Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis | Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai | 2014-09-09 |
| RE45053 | Attenuated dengue virus comprising mutations in the NS3 gene | Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai | 2014-07-29 |
| 8778671 | Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus | Alexander G. Pletnev, Joseph R. Putnak, Robert M. Chanock, Stephen S. Whitehead, Joseph E. Blaney | 2014-07-15 |
| RE45016 | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses | Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai | 2014-07-15 |
| 8632782 | Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region | Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai | 2014-01-21 |
| 8568739 | Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses | Alexander G. Pletnev, Amber R. Engel | 2013-10-29 |
| 8367074 | Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens | Mario H. Skiadopoulos, Peter L. Collins | 2013-02-05 |
| 8337860 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney | 2012-12-25 |
| 8298541 | Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae | Stephen S. Whitehead, Richard S. Bennett | 2012-10-30 |
| 8221759 | Neutralizing monoclonal antibodies to respiratory syncytial virus | Glenn Pilkington, Page S. Gilmour, Robert M. Chanock, James E. Crowe, Jr. | 2012-07-17 |
| 8168202 | Hexavalent bovine rotavirus reassortant composition designed for use in developing countries | Albert Z. Kapikian, Lone Simonsen, Timo Vesikari, Yasutaka Hoshino, David M. Morens +2 more | 2012-05-01 |
| 8075903 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 | Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley | 2011-12-13 |
| 8039003 | Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis | Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney | 2011-10-18 |
| 7951383 | Attenuated parainfluenza virus (PIV) vaccines | Peter L. Collins, Mario H. Skiadopoulos | 2011-05-31 |
| 7919301 | Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens | Mario H. Skiadopoulos, Peter L. Collins | 2011-04-05 |
| 7846455 | Attenuated chimeric respiratory syncytial virus | Peter L. Collins, Stephen S. Whitehead | 2010-12-07 |
| 7842798 | Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines | Ursula Buchholz, Peter L. Collins, Stephen S. Whitehead, Christine Krempl | 2010-11-30 |
| 7829102 | Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines | Ursula Buchholz, Peter L. Collins, Stephen S. Whitehead, Christine Krempl | 2010-11-09 |
| 7820181 | Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens | Mario H. Skiadopoulos, Peter L. Collins | 2010-10-26 |
| 7820182 | Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions | Ursula Buchholz, Peter L. Collins, Stephen S. Whitehead, Christine Krempl | 2010-10-26 |
| 7744902 | Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes | Christine Krempl, Peter L. Collins, Ursula Buchholz, Stephen S. Whitehead | 2010-06-29 |
| 7709007 | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences | Peter L. Collins, Stephen S. Whitehead, Alexander Bukreyev, Katalin Juhasz, Michael N. Teng | 2010-05-04 |